Health Dictionary Find a Doctor

Metabolic alkalosis

For patient information, click here

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Marufa Marium, M.B.B.S[2]

Synonyms and keywords:

Overview

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Marufa Marium, M.B.B.S[2]

Overview

The normal physiological pH of blood is 7.35 to 7.45. An increase above this range is known to be Alkalosis. Metabolic Alkalosis is defined as a disease state where blood pH is more than 7.45 due to secondary metabolic processes.

Historical Perspective

Alkalosis is defined as elevation of physiologic blood pH above 7.45. Metabolic alkalosis is caused by metabolic imbalance causing alkalosis by trapping Bicarbonate ions or loss of hydrogen in body. The discovery of electrochemistry of gas and electricity was first explored in 17th and 18th centuries . Later in late 1880s definition of acid was first developed and modified by numerous scientists from 1880s to 1950s until the epidemic era of Polio. Stewart combined all the ideas from pre-1950 and proposed a way of studying acid-base balance in clinical settings.

Classification

Metabolic Alkalosis can be classified according to pathophysiology, etiology and chloride responsiveness or urinary chloride concentration.

Pathophysiology

The primary pH buffers in maintaining chemical equilibrium of physiological Blood pH are alkaline Bicarbonate ions(HCO3) and acidic carbon dioxide(CO2). When there is increase amount of Bicarbonate(HCO3) in body or decrease amount of carbon dioxide or loss of hydrogen ions it causes alkalosis. Metabolic alkalosis occurs due to trapping of Bicarbonate ions (HCO3) or loss of hydrogen ions in body due to some metabolic causes for example- gastrointestinal loss of hydrogen ions, intracellular shifting of hydrogen ions, renal hydrogen loss, increased bicarbonate ions in extracellular compartment, diuretic induced alkalosis or contraction alkalosis. Patient with normal renal physiology will compensate this increase amount of bicarbonate through excretion. But impaired renal function secondary to chloride depletion, hypokalemia, hyperaldosteronism, reduced glomerular function rate, reduced effective arterial blood volume (EABV)) in heart failure or cirrhosis will lead to metabolic alkalosis. When the physiologic blood pH is above 7.45, it triggers respiratory center to cause hypoventilation, thus decreased PCO2 leading to compensatory respiratory acidosis. The PCO2 elevates from 0.5 to 0.7 mmHg per 1.0 millimole elevation in plasma bicarbonate concentration. In severe Metabolic alkalosis PCO2 can reach 60 mmHg. The mortality rate with metabolic alkalosis is 45% with arterial blood pH 7.55 to 80% with arterial blood pH of 7.65. Treatment is usually supportive based on cause of the disease.

Causes

Causes of Metabolic Alkalosis are Vomiting, Diarrhea, Diuretics, Cystic Fibrosis, Primary Hyperaldosteronism, Secondary hyperaldosteronism, laxative use, CKD, elactrolyte and nutritional imbalances, Milk-alkali syndrome, Blood transfusion, Genetic diseases for instances Bartter, Liddle, Gitelman syndrome etc. Among them, life threatening causes are loss of gastric acid, excessive use of loop and thiazide diuretics.

Differentiating Xyz from Other Diseases

Metabolic alkalosis might be consequence of several conditions such as exogenous HCO3− loads, medications and poisoning, gastrointestinal, renal, endocrine, and systemic diseases.

Epidemiology and Demographics

Metabolic Alkalosis has the highest incidence and prevalence rate among the other acid base disorder in hospitalized patient. Limited data are found on its predilection to race, age, gender, region.

Risk Factors

Common risk factors in the development of Metabolic Alkalosis include Vomiting, Milk-alkali syndrome, Severe hypokalemia, Primary hyperaldosterinism, Cushing syndrome, Diuretics use and genetic disease for instances- Bartter and gitelman Disease.

Screening

There is insufficient evidence to recommend routine screening for Metabolic alkalosis.

Natural History, Complications, and Prognosis

Common complications of Metabolic alkalosis include hypokalemia, hypomagnesaemia, hypophosphatemia, coronary arterial blood flow reduction, arrhythmia, anaerobic glycolysis, reduced ventilation leading to low arterial oxygen saturation, increased CO2, decreased blood flow to cerebral arteries leading to altered mental status, lethargy, tetany, delirium, seizure.

Diagnosis

Diagnostic Study of Choice

Arterial Blood Gas Analysis(ABG) is gold standard for diagnosis of Metabolic Alkalosis. Other laboratory tests, for instance Basic metabolic panel, serum aldosterone, serum renin, Urine analysis, urine pH, Urine chloride and sodium, Chest X-ray, Abdominal USG/CT are done to rule out the causes of metabolic alkalosis.

History and Symptoms

The hallmark of Metabolic Alkalosis is elevated HCO3 ion in serum primarily. A positive history of cystic fibrosis, Congenital Adrenal Hyperplasia, CHF, Uncontrolled HTN, Excess Antacid consumption, Calcium over supplementation, Penicillin use, Recent diuretics use, Vomiting, Diarrhea, Licorice consumption, Massive Blood transfusion are suggestive of Metabolic Alkalosis. The most common symptoms of Metabolic Alkalosis include nausea, vomiting, diarrhea, irritability, restlessness. Common symptoms of metabolic alkalosis include muscle cramp, tingling, tremor, slow respiration. Less common symptoms of metabolic alkalosis include loss of consciousness, altered mental status etc.

Physical Examination

Patients suffering from Metabolic alkalosis usually appear restless, irritable. Patients with metabolic alkalosis is usually remarkable for tachycardia/dysrhythmia, hypoxemia, Hypoxemia, Compensatory hypoventilation, Muscle cramps, Tremor, tingling and numbness in extremities, Weakness on clinical examination.

Laboratory Findings

Laboratory findings consistent with the diagnosis of Metabolic Alkalosis include ABG (pH >7.45, HCO3 >26 mEq/L, PCO2 compensates for increased HCO3 by decreasing.), high or low Serum aldosterone/Serum renin, and Urine analysis with Urine pH and high or low Urine chloride and sodium.

Electrocardiogram

An ECG may be helpful in the diagnosis of Hypokalemia, an etiology of metabolic alkalosis. Findings on an ECG diagnostic of Hypokalemia include Depression in ST segment with decreased T wave and , prominent U wave, and prolonged PR interval with widened QRS .

X-ray

There are no x-ray findings associated with Metabolic alkalosis. However, an x-ray may be helpful in the diagnosis of etiology of metabolic alkalosis, which include Cystic Fibrosis, Heart failure, Nephroblastoma, NG Suction.

Echocardiography and Ultrasound

There are no echocardiography/ultrasound findings associated with Metabolic alkalosis. However, an echocardiography/ultrasound may be helpful in the diagnosis of etiology of Metabolic Alkalosis, which include Heart failure, Cirrhosis, Cystic fibrosis, Pyloric stenosis, Adrenal adenoma, renal cell carcinoma, Renin producing tumor, Gastrocystoplasty and nephroblastoma.

CT scan

There are no CT scan findings associated with Metabolic alkalosis. However, an echocardiography/ultrasound may be helpful in the diagnosis of etiology of Metabolic Alkalosis, which include Heart failure, Cirrhosis, Cystic fibrosis, Pyloric stenosis, Adrenal adenoma, renal cell carcinoma, Renin producin tumor, Gastrocystoplasty and nephroblastoma.

MRI

There are no MRI findings associated with Metabolic alkalosis. However, an echocardiography/ultrasound may be helpful in the diagnosis of etiology of Metabolic Alkalosis, which include Heart failure, Cirrhosis, Cystic fibrosis, Pyloric stenosis, Adrenal adenoma, renal cell carcinoma, Renin producin tumor, Gastrocystoplasty and nephroblastoma.

Other Imaging Findings

There are no other imaging findings associated with Metabolic alkalosis.

Other Diagnostic Studies

Genetic testing for identifying genes involved in the pathogenesis of Metabolic Alkalosis include CFTR, SCNN1A/SCNN1B/SCNN1G, NKCC2;, SLC12A3/CLCNKB, SLC26A3 causing Cystic Fibrosis, Liddle Syndrome, Bartter syndrome, Gitelman syndrome and Congenital Chloride Diarrhhea respectively.

Treatment

Medical Therapy

Supportive therapy for Metabolic alkalosis includes volume repletion, electrolyte repletion, removal of inducing source and after stabilizing patient treatment according to etiology. Pharmacologic medical therapy is recommended among patients with electrolyte imbalances, hypervolemia, loss of GI hydrogen.

Surgery

The mainstay of treatment for metabolic alkalosis is medical therapy. Surgery is usually reserved for patients with either pyloric stenosis), Zollinger- Ellison syndrome, Villous adenoma, Conn syndrome or adrenal adenoma/ hyperplasia /carcinoma, Reno vascular hypertension, juxtaglomerular cell(renin producing) tumor, renal cell carcinoma, hemangiopericytoma, nephroblastoma.

Primary Prevention

There are no available vaccines against Metabolic alkalosis.

Secondary Prevention

Effective measures for the secondary prevention of metabolic alkalosis include resuscitation with airway, breathing, circulation, correction of electrolyte imbalance, and removal of inciting sources.

References


Template:WikiDoc Sources

Historical Perspective

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Marufa Marium, M.B.B.S[2]

Overview

Alkalosis is defined as elevation of physiologic blood pH above 7.45. Metabolic alkalosis is caused by metabolic imbalance causing alkalosis by trapping Bicarbonate ions or loss of hydrogen in body. The discovery of electrochemistry of gas and electricity was first explored in 17th and 18th centuries . Later in late 1880s definition of acid was first developed and modified by numerous scientists from 1880s to 1950s until the epidemic era of Polio. Stewart combined all the ideas from pre-1950 and proposed a way of studying acid-base balance in clinical settings.

Historical Perspective

In the beginning era of exploration of acid-base physiology, there are contribution of many scientists from 1880s to modern time. In 1880s Arrhenius defined acid for the first time as a substance which helped in increasing hydrogen ions concentration when dissolving with water. Naunyn combined definitions from Arrhenius and Faraday and came up with ideas of electrolytes determining acid-base physiology.[1] Van Slyke modified the definition of acid by Naunyn in 1920. Bronsted and Lowry defined acid as a substance donating hydrogen ion just after World War One, whereas Lewis suggested acid as acceptor of electron pair. Henderson and Hasselbalch contributed in development of Henderson-Hasselbalch equation linking pH, PCO2, HCO3 concentration in 1908 and 1916 respectively. The role of HCO3 in acid-base physiology first came up in 1950s.[2][3]

Discovery

A group of physicians from Denmark erroneously discovered metabolic alkalosis by using bicarbonate concentration in plasma during the emergence of polio epidemic in 1952.[4]

Outbreaks

The Polio epidemic triggered the development of glass electrode and detection of pH by Astrup in blood. He worked with Siggard-Anderson to build the foundation od clinical acid-base balance.[5]

Landmark Events in the Development of Treatment Strategies

From 1970 to 1980s Stewart showed detailed integration of clinical acid-base physiology and applied HCO3 centered in clinical settings.[6]



References

  1. RELMAN AS (October 1954). “What are acids and bases?”. Am J Med. 17 (4): 435–7. doi:10.1016/0002-9343(54)90118-7. PMID 13197407.
  2. Severinghaus JW (1993). “Siggaard-Andersen and the “Great Trans-Atlantic Acid-Base Debate“. Scand J Clin Lab Invest Suppl. 214: 99–104. PMID 8332859.
  3. Siggaard-Andersen O, Fogh-Andersen N (1995). “Base excess or buffer base (strong ion difference) as measure of a non-respiratory acid-base disturbance”. Acta Anaesthesiol Scand Suppl. 107: 123–8. doi:10.1111/j.1399-6576.1995.tb04346.x. PMID 8599264.
  4. Story DA (August 2004). “Bench-to-bedside review: a brief history of clinical acid-base”. Crit Care. 8 (4): 253–8. doi:10.1186/cc2861. PMC 522833. PMID 15312207.
  5. Severinghaus JW, Astrup PB (October 1985). “History of blood gas analysis. II. pH and acid-base balance measurements”. J Clin Monit. 1 (4): 259–77. doi:10.1007/BF02832819. PMID 3913750.
  6. Kellum JA (2000). “Determinants of blood pH in health and disease”. Crit Care. 4 (1): 6–14. doi:10.1186/cc644. PMC 137247. PMID 11094491.

Template:WH Template:WS

Classification

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Marufa Marium, M.B.B.S[2]

Overview

Metabolic Alkalosis can be classified according to pathophysiology, etiology and chloride responsiveness or urinary chloride concentration.

Classification

  • 1.The following classification of Metabolic Alkalosis is based on Pathophysiology[1]:
 
 
 
Metabolic Alkalosis
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Stimulation on Collecting Duct
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Primary stimulation by Mineralocorticoid Excess causing HTN: •Congenital Adrenal Hyperplasia
•Cushing Syndrome
•Primary aldosteronism
•Renin Secreting tumors
•Medications(Fluoroprednisolone, Fludrocortisone)
•Liddle Syndrome
•11 beta hydroxysteroid dehydrogenase deficiency
 
 
 
Secondary Stimulation by Chloride depletion causing normal or low blood pressure: •Vomiting
•NG tube intubation
•Congenital Chloridorrhea
•Ileostomy
•Cystic fibrosis
•Diuretics
•Bartter syndrome
•Gitelman syndrome
•Hypokalemia
  • 2.The classification based on etiologies are following:

References

  1. “Metabolic Alkalosis – Jeffrey M. Rimmer, F. John Gennari, 1987”.
  2. Galla JH, Gifford JD, Luke RG, Rome L (October 1991). “Adaptations to chloride-depletion alkalosis”. Am J Physiol. 261 (4 Pt 2): R771–81. doi:10.1152/ajpregu.1991.261.4.R771. PMID 1928424.
  3. Babior BM (October 1966). “Villous adenoma of the colon. Study of a patient with severe fluid and electrolyte disturbances”. Am J Med. 41 (4): 615–21. doi:10.1016/0002-9343(66)90223-3. PMID 5927076.
  4. Höglund P, Haila S, Socha J, Tomaszewski L, Saarialho-Kere U, Karjalainen-Lindsberg ML, Airola K, Holmberg C, de la Chapelle A, Kere J (November 1996). “Mutations of the Down-regulated in adenoma (DRA) gene cause congenital chloride diarrhoea”. Nat Genet. 14 (3): 316–9. doi:10.1038/ng1196-316. PMID 8896562.
  5. Pedroli G, Liechti-Gallati S, Mauri S, Birrer P, Kraemer R, Foletti-Jäggi C, Bianchetti MG (1995). “Chronic metabolic alkalosis: not uncommon in young children with severe cystic fibrosis”. Am J Nephrol. 15 (3): 245–50. doi:10.1159/000168839. PMID 7618650.
  6. Plawker MW, Rabinowitz SS, Etwaru DJ, Glassberg KI (August 1995). “Hypergastrinemia, dysuria-hematuria and metabolic alkalosis: complications associated with gastrocystoplasty”. J Urol. 154 (2 Pt 1): 546–9. doi:10.1097/00005392-199508000-00066. PMID 7609133.
  7. Sabatini S (March 1996). “The cellular basis of metabolic alkalosis”. Kidney Int. 49 (3): 906–17. doi:10.1038/ki.1996.125. PMID 8648937.
  8. Lifton RP, Dluhy RG, Powers M, Rich GM, Cook S, Ulick S, Lalouel JM (January 1992). “A chimaeric 11 beta-hydroxylase/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension”. Nature. 355 (6357): 262–5. doi:10.1038/355262a0. PMID 1731223.
  9. Warnock DG (January 1998). “Liddle syndrome: an autosomal dominant form of human hypertension”. Kidney Int. 53 (1): 18–24. doi:10.1046/j.1523-1755.1998.00728.x. PMID 9452995.
  10. Kurtz I (October 1998). “Molecular pathogenesis of Bartter’s and Gitelman’s syndromes”. Kidney Int. 54 (4): 1396–410. doi:10.1046/j.1523-1755.1998.00124.x. PMID 9767561.

Template:WH Template:WS

Pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Marufa Marium, M.B.B.S[2]

Overview

The normal physiological pH of blood is 7.35 to 7.45. An increase above this range is known to be Alkalosis. Metabolic Alkalosis is defined as a disease state where blood pH is more than 7.45 due to secondary metabolic processes. The primary pH buffers in maintaining chemical equilibrium of physiological Blood pH are alkaline Bicarbonate ions(HCO3) and acidic carbon dioxide(CO2). When there is increase amount of Bicarbonate(HCO3) in body or decrease amount of carbon dioxide or loss of hydrogen ions it causes alkalosis. Metabolic alkalosis occurs due to trapping of Bicarbonate ions (HCO3) or loss of hydrogen ions in body due to some metabolic causes for example- gastrointestinal loss of hydrogen ions, intracellular shifting of hydrogen ions, renal hydrogen loss, increased bicarbonate ions in extracellular compartment, diuretic induced alkalosis or contraction alkalosis. Patient with normal renal physiology will compensate this increase amount of bicarbonate through excretion. But impaired renal function secondary to chloride depletion, hypokalemia, hyperaldosteronism, reduced glomerular function rate, reduced effective arterial blood volume (EABV)) in heart failure or cirrhosis will lead to metabolic alkalosis. When the physiologic blood pH is above 7.45, it triggers respiratory center to cause hypoventilation, thus decreased PCO2 leading to compensatory respiratory acidosis. The PCO2 elavates from 0.5 to 0.7 mmHg per 1.0 millimole elevation in plasma bicarbonate concentration. In severe Metabolic alkalosis PCO2 can reach 60 mmHg. The mortality rate with metabolic alkalosis is 45% with arterial blood pH 7.55 to 80% with arterial blood pH of 7.65. Supportive Treatment is usually given according to cause of the disease.

Pathophysiology

H+ loss

Gastrointestinal loss

Renal

Elevated HCO3- level in serum

  • Intake of NaCO3, citrate, baking powder, lactate and acetate.

Transport of H+ to IC space

  • Occurs in hypokalemia. Decreased extracellular K+, potassium transports from the cells, and to keep electrical potential in a balanced state, Transport of H+ to IC space.

Contraction Alkalosis

  • Loss of low concerntation of HCO3 mixed H2O in EC space by diuretics. HCO3 is elevated in serum..

Compensatory mechanism of Metabolic Alkalosis

  • hypoventilation (respiratory compensation) elevates pH by restoring carbon dioxide (CO2) through . Carbonic acid is generated by CO2. The acidic medium is created for compensation.
  • The pCO2 elevates from 0.5 to 1 per 1 u serum HCO3 elevation.
  • Body can compensate up tp 55-60 mmHg of partial pressure of CO2.
  • Increased secretion of HCO3 (bicarbonate) by kidney is done.

Genetics

  • Genes involved in the pathogenesis of Metabolic Alkalosis include CFTR, SCNN1A/SCNN1B/SCNN1G[10], NKCC2[11] SLC12A3/CLCNKB[12] and SLC26A3 [13] causing Cystic Fibrosis, Liddle Syndrome, Bartter syndrome, Gitelman syndrome and Congenital Chloride Diarrhhea respectively.

Associated Conditions

Conditions associated with metabolic alkalosis :

Gross Pathology

    • There is no specific gross pathological finding related to metabolic alkalosis. Gross characteristics are dependent on specific cause of metabolic alkalosis.

Microscopic Pathology

    • There is no specific microscopic pathological finding related to metabolic alkalosis. Gross characteristics are dependent on specific cause of metabolic alkalosis.


References

  1. 1.0 1.1 Galla JH, Gifford JD, Luke RG, Rome L (October 1991). “Adaptations to chloride-depletion alkalosis”. Am J Physiol. 261 (4 Pt 2): R771–81. doi:10.1152/ajpregu.1991.261.4.R771. PMID 1928424.
  2. 2.0 2.1 Babior BM (October 1966). “Villous adenoma of the colon. Study of a patient with severe fluid and electrolyte disturbances”. Am J Med. 41 (4): 615–21. doi:10.1016/0002-9343(66)90223-3. PMID 5927076.
  3. 3.0 3.1 Höglund P, Haila S, Socha J, Tomaszewski L, Saarialho-Kere U, Karjalainen-Lindsberg ML, Airola K, Holmberg C, de la Chapelle A, Kere J (November 1996). “Mutations of the Down-regulated in adenoma (DRA) gene cause congenital chloride diarrhoea”. Nat Genet. 14 (3): 316–9. doi:10.1038/ng1196-316. PMID 8896562.
  4. 4.0 4.1 Pedroli G, Liechti-Gallati S, Mauri S, Birrer P, Kraemer R, Foletti-Jäggi C, Bianchetti MG (1995). “Chronic metabolic alkalosis: not uncommon in young children with severe cystic fibrosis”. Am J Nephrol. 15 (3): 245–50. doi:10.1159/000168839. PMID 7618650.
  5. 5.0 5.1 Plawker MW, Rabinowitz SS, Etwaru DJ, Glassberg KI (August 1995). “Hypergastrinemia, dysuria-hematuria and metabolic alkalosis: complications associated with gastrocystoplasty”. J Urol. 154 (2 Pt 1): 546–9. doi:10.1097/00005392-199508000-00066. PMID 7609133.
  6. 6.0 6.1 Sabatini S (March 1996). “The cellular basis of metabolic alkalosis”. Kidney Int. 49 (3): 906–17. doi:10.1038/ki.1996.125. PMID 8648937.
  7. 7.0 7.1 Lifton RP, Dluhy RG, Powers M, Rich GM, Cook S, Ulick S, Lalouel JM (January 1992). “A chimaeric 11 beta-hydroxylase/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension”. Nature. 355 (6357): 262–5. doi:10.1038/355262a0. PMID 1731223.
  8. 8.0 8.1 Warnock DG (January 1998). “Liddle syndrome: an autosomal dominant form of human hypertension”. Kidney Int. 53 (1): 18–24. doi:10.1046/j.1523-1755.1998.00728.x. PMID 9452995.
  9. 9.0 9.1 Kurtz I (October 1998). “Molecular pathogenesis of Bartter’s and Gitelman’s syndromes”. Kidney Int. 54 (4): 1396–410. doi:10.1046/j.1523-1755.1998.00124.x. PMID 9767561.
  10. Tetti M, Monticone S, Burrello J, Matarazzo P, Veglio F, Pasini B, Jeunemaitre X, Mulatero P (March 2018). “Liddle Syndrome: Review of the Literature and Description of a New Case”. Int J Mol Sci. 19 (3). doi:10.3390/ijms19030812. PMC 5877673. PMID 29534496.
  11. Simon DB, Karet FE, Rodriguez-Soriano J, Hamdan JH, DiPietro A, Trachtman H, Sanjad SA, Lifton RP (October 1996). “Genetic heterogeneity of Bartter’s syndrome revealed by mutations in the K+ channel, ROMK”. Nat Genet. 14 (2): 152–6. doi:10.1038/ng1096-152. PMID 8841184.
  12. Vargas-Poussou R, Dahan K, Kahila D, Venisse A, Riveira-Munoz E, Debaix H, Grisart B, Bridoux F, Unwin R, Moulin B, Haymann JP, Vantyghem MC, Rigothier C, Dussol B, Godin M, Nivet H, Dubourg L, Tack I, Gimenez-Roqueplo AP, Houillier P, Blanchard A, Devuyst O, Jeunemaitre X (April 2011). “Spectrum of mutations in Gitelman syndrome”. J Am Soc Nephrol. 22 (4): 693–703. doi:10.1681/ASN.2010090907. PMC 3065225. PMID 21415153.
  13. Kamal NM, Khan HY, El-Shabrawi M, Sherief LM (May 2019). “Congenital chloride losing diarrhea: A single center experience in a highly consanguineous population”. Medicine (Baltimore). 98 (22): e15928. doi:10.1097/MD.0000000000015928. PMC 6709049 Check |pmc= value (help). PMID 31145360. Vancouver style error: initials (help)

Template:WH Template:WS

Causes

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Marufa Marium, M.B.B.S[2]

Overview

Causes of Metabolic Alkalosis are Vomiting, Diarrhea, Diuretics, Cystic Fibrosis, Primary Hyperaldosteronism, Secondary hyperaldosteronism, laxative use, CKD, elactrolyte and nutritional imbalances, Milk-alkali syndrome, Blood transfusion, Genetic diseases for instances Bartter, Liddle, Gitelman syndrome etc. Among them, life threatening causes are loss of gastric acid, excessive use of loop and thiazide diuretics.


Causes

There are several causes of metabolic alkalosis. Life threatening causes of severe metabolic alkalosis (pH 7.55 to 7.65) may result in death (45% to 80%) or permanent disability within 24 hours if left untreated.[1]

Common Causes

Causes by Organ System

Cardiovascular Dilated cardiomyopathy, Malignant hypertension, Renovascular hypertension
Chemical / poisoning No underlying causes
Dermatologic No underlying causes
Drug Side Effect Aldosterone, Carbenoxolone, Diuretics, Ethacrynic Acid, Fludrocortisone, Glucocorticoids, Intravenous Pencillins, Laxatives, Lydia Pinkham’s vegetable compound, Mineralocorticoids, Pramipexole, Sodium bicarbonate, Tolazoline, Tromethamine
Ear Nose Throat No underlying causes
Endocrine Cushing syndrome, Glucocorticoid-remediable hyperaldosteronism, Hyperaldosteronism, 11 beta hydroxylase deficiency, C17-hydroxylase deficiency, Conn syndrome, Bilateral adrenal hyperplasia, Adrenal adenoma, Adrenal carcinoma
Environmental No underlying causes
Gastroenterologic Gastric fistula, Villous adenoma, VIPoma, Congenital chloride diarrhea, Cystic fibrosis
Genetic 11 beta hydroxylase deficiency, Bartter syndrome, C17-hydroxylase deficiency, Congenital chloride diarrhea, Cystic fibrosis, Gietelman syndrome, Glucocorticoid receptor defect, Liddle syndrome, SeSAME syndrome
Hematologic No underlying causes
Iatrogenic Massive blood transfusion, Nasogastric suction
Infectious Disease No underlying causes
Musculoskeletal / Ortho No underlying causes
Neurologic No underlying causes
Nutritional / Metabolic Hypercalcemia, Hypokalemia, Hypomagnesemia, Refeeding syndrome, Glucocorticoid receptor defect, Glycyrrhizic acid, Licorice
Obstetric/Gynecologic No underlying causes
Oncologic Adrenal adenoma, Adrenal carcinoma, Conn syndrome, Hemangiopericytoma,VIPoma, Juxtaglomerular cell tumor
Opthalmologic No underlying causes
Overdose / Toxicity Aldosterone, Carbenoxolone, Diuretics, Fludrocortisone, Glucocorticoids, Intravenous Pencillins, Laxatives, Lydia Pinkham’s vegetable compound, Mineralocorticoids, Sodium bicarbonate, Tolazoline, Tromethamine
Psychiatric No underlying causes
Pulmonary Cystic fibrosis
Renal / Electrolyte Bilateral adrenal hyperplasia, Hypokalemic distal renal tubular acidosis, Juxtaglomerular cell tumor, Milk-alkali syndrome, Renovascular hypertension, Bartter syndrome, Gietelman syndrome, Liddle syndrome, Adrenal adenoma, Adrenal carcinoma
Rheum / Immune / Allergy No underlying causes
Sexual Cystic fibrosis
Trauma No underlying causes
Urologic No underlying causes
Dental No underlying causes
Miscellaneous Chewing tobacco, Glycyrrhizic acid, Licorice, Posthypercapnia, Vomiting, Laxatives, Refeeding syndrome, Milk-alkali syndrome

Causes in Alphabetical Order

  1. Tripathy S (October 2009). “Extreme metabolic alkalosis in intensive care”. Indian J Crit Care Med. 13 (4): 217–20. doi:10.4103/0972-5229.60175. PMC 2856150. PMID 20436691.
  2. Galla JH, Gifford JD, Luke RG, Rome L (October 1991). “Adaptations to chloride-depletion alkalosis”. Am J Physiol. 261 (4 Pt 2): R771–81. doi:10.1152/ajpregu.1991.261.4.R771. PMID 1928424.
  3. Pedroli G, Liechti-Gallati S, Mauri S, Birrer P, Kraemer R, Foletti-Jäggi C, Bianchetti MG (1995). “Chronic metabolic alkalosis: not uncommon in young children with severe cystic fibrosis”. Am J Nephrol. 15 (3): 245–50. doi:10.1159/000168839. PMID 7618650.
  4. Sabatini S (March 1996). “The cellular basis of metabolic alkalosis”. Kidney Int. 49 (3): 906–17. doi:10.1038/ki.1996.125. PMID 8648937.
  5. Höglund P, Haila S, Socha J, Tomaszewski L, Saarialho-Kere U, Karjalainen-Lindsberg ML, Airola K, Holmberg C, de la Chapelle A, Kere J (November 1996). “Mutations of the Down-regulated in adenoma (DRA) gene cause congenital chloride diarrhoea”. Nat Genet. 14 (3): 316–9. doi:10.1038/ng1196-316. PMID 8896562.
  6. Kurtz I (October 1998). “Molecular pathogenesis of Bartter’s and Gitelman’s syndromes”. Kidney Int. 54 (4): 1396–410. doi:10.1046/j.1523-1755.1998.00124.x. PMID 9767561.
  7. Warnock DG (January 1998). “Liddle syndrome: an autosomal dominant form of human hypertension”. Kidney Int. 53 (1): 18–24. doi:10.1046/j.1523-1755.1998.00728.x. PMID 9452995.
  8. Plawker MW, Rabinowitz SS, Etwaru DJ, Glassberg KI (August 1995). “Hypergastrinemia, dysuria-hematuria and metabolic alkalosis: complications associated with gastrocystoplasty”. J Urol. 154 (2 Pt 1): 546–9. doi:10.1097/00005392-199508000-00066. PMID 7609133.
Differentiating Metabolic alkalosis from other Diseases

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sadaf Sharfaei M.D.[2]

Overview

Metabolic alkalosis might be consequence of several conditions such as exogenous HCO3 loads, medications and poisoning, gastrointestinal, renal, endocrine, and systemic diseases.

Metabolic Alkalosis

Differential diagnosis of metabolic alkalosis is as follow:

Category Disease Mechanism Clinical Paraclinical Gold standard diagnosis Other findings
Symptoms Signs Lab data
ABG Chemistry Enzyme Renal function
Hydrogen loss Accumulation of base Chloride depletion Mineralocorticoid excess Fever Dyspnea Edema Toxic/ill BP Dehydration HCO3 paCO2 O2 Cl K+ Na+ Ca+ Mg+ Renin Bun Cr Urine Cl
Exogenous HCO3 loads Acute alkali administration[1] + + + Nl Nl Nl Clinical manifestations
Milk−alkali syndrome[2] + + + + + Nl Clinical manifestationsk + exclusion of other causes of hypercalcemia
Transfusion[3] + ± ± + ↓/↑ Nl to ↑ Nl to ↑ Nl History of administration of large quantities of blood products that contain sodium citrate
Drugs/Medication Chloruretic diuretics[4] + + + + Nl Nl Nl Nl to ↑ Nl to ↑ History of diuretic use
Penicillin[5] + Nl Nl Nl Nl Nl Nl History of penicillin use
  • Not applicable
Licorice[6][7] + + + Nl to ↑ Nl Nl Nl Nl to ↑ Nl to ↑ Nl Clinical manifestations
Laxative abuse[8] + + ± + + Nl Nl Nl to ↑ Nl High level of suspicion
Antacids[9][10]
  • Aluminum hydroxide
  • Sodium polystyrene sulfonate  
+ + Nl Nl Nl Nl Nl to ↑ Nl to ↑ Nl Clinical manifestations
  • Not applicable
Category Disease Hydrogen loss Accumulation of base Chloride depletion Mineralocorticoid excess Fever Dyspnea Edema Toxic/ill BP Dehydration HCO3 paCO2 O2 Cl K+ Na+ Ca+ Mg+ Renin Bun Cr Urine Cl Gold standard diagnosis Other findings
Gastrointestinal origin Vomiting[11] + + ± + + Nl Nl Nl Nl to ↑ Nl Clinical manifestations
  • Not applicable
Nasogastric tube suction[12] + + + + Nl Nl Nl Nl to ↑ Nl Clinical manifestations
Zollinger−Ellison syndrome[13] + + + + Nl Nl Nl Nl to ↑ Nl Serum gastrin concentration + secretin stimulation test 
Bulimia nervosa[14] + + ± + + Nl Nl Nl to ↑ Nl High level of suspicion
Congenital chloridorrhea[15] + + ± + + Nl Nl to ↑ Nl to ↑ Nl to ↑ Clinical manifestations+ lab findings
Pyloric stenosis[16] + + + + Nl ↓ ↑ Nl Nl Nl to ↑ Nl Physical exam + imaging
  • Palpation of the “olive”
Villous adenoma[17] + + + + Nl Nl to ↑ Nl Colonoscopy
Gastrocystoplasty[18] + + Nl Nl Nl Nl Nl Nl Nl to ↑ Nl to ↑ Nl History of operation
Category Disease Hydrogen loss Accumulation of base Chloride depletion Mineralocorticoid excess Fever Dyspnea Edema Toxic/ill BP Dehydration HCO3 paCO2 O2 Cl K+ Na+ Ca+ Mg+ Renin Bun Cr Urine Cl Gold standard diagnosis Other findings
Renal origin Posthypercapnic state[19] + + ± Nl ↑↑ Nl Nl Nl Nl Nl Lab findings
Hypomagnesemia[20] + Nl Nl Nl Nl Nl Nl Nl Lab findings
  • Not applicable
Hypokalemia[21] + Nl Nl Nl Nl Nl Nl Nl Lab findings
  • Not applicable
Bartter’s syndrome[22] + + Nl + Nl ↓↓ Nl Nl to ↑ Nl to ↑ Nl Genetic testing
Gitelman’s syndrome[23][24] + + + Nl ↓↓ Nl Nl Nl Nl Genetic testing
Renal artery stenosis[25] + + + + + + Nl Nl Clinical manifestations+ imaging
Liddle syndrome[26] + + + Nl ↓↓ Nl Nl Nl Nl Genetic testing
  • Not applicable
Renal tumors[27] + + + + + + Nl Nl Biopsy
  • Not applicable
Endocrine Cushing’s syndrome[28] + + + + Nl Nl Nl 24−hour urinary cortisol excretion + low−dose dexamethasone suppression test
Hyperaldosteronism Primary[29] + + + + Nl Nl to ↓ Nl Nl Lab findings
Secondary[30] + + + + + + Nl Nl Nl Lab findings
Congenital adrenal hyperplasia 11β−Hydroxylase deficiency[31] + + + Nl Nl Nl Nl Nl Genetic testing
17α−Hydroxylase deficiency[32] + + + Nl Nl Nl Nl Nl Genetic testing
Systemic Cystic fibrosis[33] + + + + + Nl Nl Nl Nl Nl to ↑ Nl Genetic testing
Category Disease Hydrogen loss Accumulation of base Chloride depletion Mineralocorticoid excess Fever Dyspnea Edema Toxic/ill BP Dehydration HCO3 paCO2 O2 Cl K+ Na+ Ca+ Mg+ Renin Bun Cr Urine Cl Gold standard diagnosis Other findings

References

  1. Máttar, João A.; Weil, Max Harry; Shubin, Herbert; Stein, Leon (1974). “Cardiac arrest in the critically III”. The American Journal of Medicine. 56 (2): 162–168. doi:10.1016/0002-9343(74)90593-2. ISSN 0002-9343.
  2. Abreo, Kenneth (1993). “The Milk-Alkali Syndrome”. Archives of Internal Medicine. 153 (8): 1005. doi:10.1001/archinte.1993.00410080065011. ISSN 0003-9926.
  3. Gupta M, Wadhwa NK, Bukovsky R (January 2004). “Regional citrate anticoagulation for continuous venovenous hemodiafiltration using calcium-containing dialysate”. Am. J. Kidney Dis. 43 (1): 67–73. PMID 14712429.
  4. Luke, R. G.; Galla, J. H. (2012). “It Is Chloride Depletion Alkalosis, Not Contraction Alkalosis”. Journal of the American Society of Nephrology. 23 (2): 204–207. doi:10.1681/ASN.2011070720. ISSN 1046-6673.
  5. Zaki, SyedAhmed; Lad, Vijay (2011). “Piperacillin-tazobactam-induced hypokalemia and metabolic alkalosis”. Indian Journal of Pharmacology. 43 (5): 609. doi:10.4103/0253-7613.84986. ISSN 0253-7613.
  6. Meltem, Akkas Camkurt; Figen, Coskun; Nalan, Metin Aksu; Mahir, Kunt; Sebnem, Bozkurt; Mehlika, Isildak; Kasim, Kilic Ahmet; Miyase, Bayraktar (2009). “A hypokalemic muscular weakness after licorice ingestion: a case report”. Cases Journal. 2 (1): 8053. doi:10.4076/1757-1626-2-8053. ISSN 1757-1626.
  7. Lin, Shih-Hua; Yang, Sung-Sen; Chau, Tom; Halperin, Mitchell L. (2003). “An Unusual Cause of Hypokalemic Paralysis: Chronic Licorice Ingestion”. The American Journal of the Medical Sciences. 325 (3): 153–156. doi:10.1097/00000441-200303000-00008. ISSN 0002-9629.
  8. Roerig, James L.; Steffen, Kristine J.; Mitchell, James E.; Zunker, Christie (2010). “Laxative Abuse”. Drugs. 70 (12): 1487–1503. doi:10.2165/11898640-000000000-00000. ISSN 0012-6667.
  9. Sahani, Mandeep M.; Brennan, John F.; Nwakanma, Chukwuemeka; Chow, May T.; Ing, Todd S.; Leehey, David J. (2001). “Metabolic Alkalosis in a Hemodialysis Patient After Ingestion of a Large Amount of an Antacid Medication”. Artificial Organs. 25 (4): 313–315. doi:10.1046/j.1525-1594.2001.06714.x. ISSN 0160-564X.
  10. Vanpee, Dominique; Delgrange, Etienne; Gillet, Jean-Bernard; Donckier, Julian (2000). “Ingestion of antacid tablets (Rennie®) and acute confusion”. The Journal of Emergency Medicine. 19 (2): 169–171. doi:10.1016/S0736-4679(00)00206-7. ISSN 0736-4679.
  11. Gan, Tong J.; Meyer, Tricia; Apfel, Christian C.; Chung, Frances; Davis, Peter J.; Eubanks, Steve; Kovac, Anthony; Philip, Beverly K.; Sessler, Daniel I.; Temo, James; Tram??r, Martin R.; Watcha, Mehernoor (2003). “Consensus Guidelines for Managing Postoperative Nausea and Vomiting”. Anesthesia & Analgesia: 62–71. doi:10.1213/01.ANE.0000068580.00245.95. ISSN 0003-2999.
  12. Gilbertson, Heather Ruth; Rogers, Elizabeth Jessie; Ukoumunne, Obioha Chukwunyere (2011). “Determination of a Practical pH Cutoff Level for Reliable Confirmation of Nasogastric Tube Placement”. Journal of Parenteral and Enteral Nutrition. 35 (4): 540–544. doi:10.1177/0148607110383285. ISSN 0148-6071.
  13. Hung, Patrick D.; Schubert, Mitchell L.; Mihas, Anastasios A. (2003). “Zollinger-Ellison syndrome”. Current Treatment Options in Gastroenterology. 6 (2): 163–170. doi:10.1007/s11938-003-0017-6. ISSN 1092-8472.
  14. Shapiro, Jennifer R.; Berkman, Nancy D.; Brownley, Kimberly A.; Sedway, Jan A.; Lohr, Kathleen N.; Bulik, Cynthia M. (2007). “Bulimia nervosa treatment: A systematic review of randomized controlled trials”. International Journal of Eating Disorders. 40 (4): 321–336. doi:10.1002/eat.20372. ISSN 0276-3478.
  15. Wedenoja, S.; Hã–Glund, P.; Holmberg, C. (2010). “Review article: the clinical management of congenital chloride diarrhoea”. Alimentary Pharmacology & Therapeutics. 31 (4): 477–485. doi:10.1111/j.1365-2036.2009.04197.x. ISSN 0269-2813. C1 control character in |last2= at position 3 (help)
  16. Bakal, Unal; Sarac, Mehmet; Aydin, Mustafa; Tartar, Tugay; Kazez, Ahmet (2016). “Recent changes in the features of hypertrophic pyloric stenosis”. Pediatrics International. 58 (5): 369–371. doi:10.1111/ped.12860. ISSN 1328-8067.
  17. Gennari, F. J.; Weise, W. J. (2008). “Acid-Base Disturbances in Gastrointestinal Disease”. Clinical Journal of the American Society of Nephrology. 3 (6): 1861–1868. doi:10.2215/CJN.02450508. ISSN 1555-9041.
  18. Kurzrock, Eric A.; Baskin, Laurence S.; Kogan, Barry A. (1998). “GASTROCYSTOPLASTY: LONG-TERM FOLLOWUP”. The Journal of Urology. 160 (6): 2182–2186. doi:10.1016/S0022-5347(01)62289-4. ISSN 0022-5347.
  19. Banga, Amit; Khilnani, G. C. (2009). “Post-hypercapnic Alkalosis is Associated with Ventilator Dependence and Increased ICU stay”. COPD: Journal of Chronic Obstructive Pulmonary Disease. 6 (6): 437–440. doi:10.3109/15412550903341448. ISSN 1541-2555.
  20. Elisaf M, Milionis H, Siamopoulos KC (1997). “Hypomagnesemic hypokalemia and hypocalcemia: clinical and laboratory characteristics”. Miner Electrolyte Metab. 23 (2): 105–12. PMID 9252977.
  21. Galla JH (February 2000). “Metabolic alkalosis”. J. Am. Soc. Nephrol. 11 (2): 369–75. PMID 10665945.
  22. Simon, David B.; Karet, Fiona E.; Hamdan, Jahed M.; Pietro, Antonio Di; Sanjad, Sami A.; Lifton, Richard P. (1996). “Bartter’s syndrome, hypokalaemic alkalosis with hypercalciuria, is caused by mutations in the Na–K–2CI cotransporter NKCC2”. Nature Genetics. 13 (2): 183–188. doi:10.1038/ng0696-183. ISSN 1061-4036.
  23. Fremont, Oliver T.; Chan, James C. M. (2012). “Understanding Bartter syndrome and Gitelman syndrome”. World Journal of Pediatrics. 8 (1): 25–30. doi:10.1007/s12519-012-0333-9. ISSN 1708-8569.
  24. Colussi G, Macaluso M, Brunati C, Minetti L (1994). “Calcium metabolism and calciotropic hormone levels in Gitelman’s syndrome”. Miner Electrolyte Metab. 20 (5): 294–301. PMID 7700218.
  25. Safian, Robert D.; Textor, Stephen C. (2001). “Renal-Artery Stenosis”. New England Journal of Medicine. 344 (6): 431–442. doi:10.1056/NEJM200102083440607. ISSN 0028-4793.
  26. Salih, Mahdi; Gautschi, Ivan; van Bemmelen, Miguel X.; Di Benedetto, Michael; Brooks, Alice S.; Lugtenberg, Dorien; Schild, Laurent; Hoorn, Ewout J. (2017). “A Missense Mutation in the Extracellular Domain ofαENaC Causes Liddle Syndrome”. Journal of the American Society of Nephrology. 28 (11): 3291–3299. doi:10.1681/ASN.2016111163. ISSN 1046-6673.
  27. Lasseigne, Brittany N.; Brooks, James D. (2018). “The Role of DNA Methylation in Renal Cell Carcinoma”. Molecular Diagnosis & Therapy. doi:10.1007/s40291-018-0337-9. ISSN 1177-1062.
  28. Araujo Castro, Marta; Marazuela Azpiroz, Mónica (2018). “Two types of ectopic Cushing syndrome or a continuum? Review”. Pituitary. doi:10.1007/s11102-018-0894-2. ISSN 1386-341X.
  29. Martell-Claros, Nieves; Abad-Cardiel, María; Alvarez-Alvarez, Beatriz; García-Donaire, José A.; Pérez, Cristina Fernández (2015). “Primary aldosteronism and its various clinical scenarios”. Journal of Hypertension. 33 (6): 1226–1232. doi:10.1097/HJH.0000000000000546. ISSN 0263-6352.
  30. Monticone S, Losano I, Tetti M, Buffolo F, Veglio F, Mulatero P (May 2018). “Diagnostic approach to low renin hypertension”. Clin. Endocrinol. (Oxf). doi:10.1111/cen.13741. PMID 29758100.
  31. Baş F, Toksoy G, Ergun-Longmire B, Uyguner ZO, Abalı ZY, Poyrazoğlu Ş, Karaman V, Avcı Ş, Altunoğlu U, Bundak R, Karaman B, Başaran S, Darendeliler F (April 2018). “Prevalence, clinical characteristics and long-term outcomes of classical 11 β-hydroxylase deficiency (11BOHD) in Turkish population and novel mutations in CYP11B1 gene”. J. Steroid Biochem. Mol. Biol. doi:10.1016/j.jsbmb.2018.04.001. PMID 29626607.
  32. Goldsmith, Oliver; Solomon, David H.; Horton, Richard (1967). “Hypogonadism and Mineralocorticoid Excess”. New England Journal of Medicine. 277 (13): 673–677. doi:10.1056/NEJM196709282771302. ISSN 0028-4793.
  33. Bates CM, Baum M, Quigley R (February 1997). “Cystic fibrosis presenting with hypokalemia and metabolic alkalosis in a previously healthy adolescent”. J. Am. Soc. Nephrol. 8 (2): 352–5. PMID 9048354.
Epidemiology and Demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

Overview

Metabolic Alkalosis has the highest incidence and prevalence rate among the other acid base disorder in hospitalized patient. Limited data are found on its predilection to race, age, gender, region.

Epidemiology and Demographics

Incidence

  • The incidence of metabolic alkalosis is highest among all other acid based disorders. The incidence of metabolic alkalosis is approximately 51% in hospitalized patient.[1]

Prevalence

  • Metabolic Alkalosis is shown to occur in 70% of 13430 cases in a study.[2]

Case-fatality rate/Mortality rate


Age

  • Patients of all age groups may develop Metabolic Alkalosis.

Race

  • There is no racial predilection to Metabolic alkalosis.

Gender

  • Metabolic Alkalosis affects men and women equally.

Region

  • There is no regional predilection for Metabolic Alkalosis.

Developed Countries

  • There is no sufficient data specifically mentioning population from developed countries.

Developing Countries

  • There is no sufficient data specifically mentioning population from developing countries.

References

  1. “Alkalosis – StatPearls – NCBI Bookshelf”.
  2. Hodgkin JE, Soeprono FF, Chan DM (December 1980). “Incidence of metabolic alkalemia in hospitalized patients”. Crit Care Med. 8 (12): 725–8. doi:10.1097/00003246-198012000-00005. PMID 6778655.

Template:WH Template:WS

Risk Factors

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Marufa Marium, M.B.B.S[2]

Overview

Common risk factors in the development of Metabolic Alkalosis include Vomiting, Milk-alkali syndrome, Severe hypokalemia, Primary hyperaldosterinism, Cushing syndrome, Diuretics use and genetic disease for instances- Bartter and gitelman Disease.

Risk Factors

  • Common risk factors in the development of Metabolic Alkalosis include Vomiting, Milk-alkali syndrome, Severe hypokalemia, Primary hyperaldosterinism, Cushing syndrome, Diuretics use and genetic disease for instances- Bartter and Gitelman Disease.

Common Risk Factors

References

  1. Pedroli G, Liechti-Gallati S, Mauri S, Birrer P, Kraemer R, Foletti-Jäggi C, Bianchetti MG (1995). “Chronic metabolic alkalosis: not uncommon in young children with severe cystic fibrosis”. Am J Nephrol. 15 (3): 245–50. doi:10.1159/000168839. PMID 7618650.
  2. Sabatini S (March 1996). “The cellular basis of metabolic alkalosis”. Kidney Int. 49 (3): 906–17. doi:10.1038/ki.1996.125. PMID 8648937.
  3. Babior BM (October 1966). “Villous adenoma of the colon. Study of a patient with severe fluid and electrolyte disturbances”. Am J Med. 41 (4): 615–21. doi:10.1016/0002-9343(66)90223-3. PMID 5927076.
  4. Höglund P, Haila S, Socha J, Tomaszewski L, Saarialho-Kere U, Karjalainen-Lindsberg ML, Airola K, Holmberg C, de la Chapelle A, Kere J (November 1996). “Mutations of the Down-regulated in adenoma (DRA) gene cause congenital chloride diarrhoea”. Nat Genet. 14 (3): 316–9. doi:10.1038/ng1196-316. PMID 8896562.
  5. Kurtz I (October 1998). “Molecular pathogenesis of Bartter’s and Gitelman’s syndromes”. Kidney Int. 54 (4): 1396–410. doi:10.1046/j.1523-1755.1998.00124.x. PMID 9767561.
  6. Warnock DG (January 1998). “Liddle syndrome: an autosomal dominant form of human hypertension”. Kidney Int. 53 (1): 18–24. doi:10.1046/j.1523-1755.1998.00728.x. PMID 9452995.
  7. Plawker MW, Rabinowitz SS, Etwaru DJ, Glassberg KI (August 1995). “Hypergastrinemia, dysuria-hematuria and metabolic alkalosis: complications associated with gastrocystoplasty”. J Urol. 154 (2 Pt 1): 546–9. doi:10.1097/00005392-199508000-00066. PMID 7609133.

Template:WH Template:WS

Screening

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Marufa Marium, M.B.B.S[2]

Overview

There is insufficient evidence to recommend routine screening for Metabolic alkalosis.

Screening

There is insufficient evidence to recommend routine screening for Metabolic alkalosis. But there are certain etiologies of metabolic alkalosis should be screened for early diagnosis.


References

Template:WH Template:WS

Natural History, Complications and Prognosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Marufa Marium, M.B.B.S[2]

Overview

Common complications of Metabolic alkalosis include hypokalemia, hypomagnesaemia, hypophosphatemia, coronary arterial blood flow reduction, arrhythmia, anaerobic glycolysis, reduced ventilation leading to low arterial oxygen saturation, increased CO2, decreased blood flow to cerebral arteries leading to altered mental status, lethargy, tetany, delirium, seizure.


Natural History, Complications, and Prognosis

Natural History

  • The mortality rate with metabolic alkalosis is 45% with arterial blood pH 7.55 to 80% with arterial blood pH of 7.65.

Complications

  • Common complications of Metabolic alkalosis include:
    • Electrolyte imbalances: hypokalemia, hypomagnesaemia, hypophosphatemia
    • Coronary arterial blood flow reduction leading to angina, refractory arrhythmia
    • Anaerobic glycolysis
    • Reduced ventilation leading to low arterial oxygen saturation, increased CO2
    • Decreased blood flow to cerebral arteries leading to altered mental status, lethargy, tetany, delirium, seizure. .

Prognosis

  • Early stabilization of patient is associated with the most favorable prognosis.


References

Template:WH Template:WS

Diagnosis

Diagnosis

Diagnostic study of choice | History and Symptoms | Physical Examination | Laboratory Findings | Electrocardiogram | X-Ray Findings | Echocardiography and Ultrasound | CT-Scan Findings | MRI Findings | Other Imaging Findings | Other Diagnostic Studies

Treatment

Treatment

Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies

Case Studies

Case Studies

Case #1

Related Chapters

Template:WikiDoc Sources

Looking for the patient version?

Back to the patient-friendly article

© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH